No previous studies have quantified peptidergic nerve fiber marker anti-CGRP-I/II in the TIPN mice model to allow the distinction between peptidergic and total IENF concerning neuropathy and gabapentin analgesic effects. This evidence concerns the gene CALCA and neuropathy.